Grant of Exclusive License. 1. Licensor hereby grants to Licensee an exclusive worldwide license with the right to sublicense others, to make, have made, use, sell and lease the Products described in the Licensed Patent Rights with reach-through rights reserved to Licensor.
Grant of Exclusive License. Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee on behalf of itself and its Affiliates an exclusive (even as to Licensor and its Affiliates), irrevocable, perpetual and transferable license under the Licensed Intellectual Property to manufacture, have manufactured, use, market, sell, have sold, offer to sell, import or otherwise exploit the Product in the Field of Use in the Territory, with the right to grant sublicenses subject to Section 2.2.
Grant of Exclusive License. Subject to the other applicable terms and conditions of this Agreement, ICN hereby grants to Schering, as of the Effective Date, (a) the exclusive licenses, exclusive even with respect to ICN, to make, have made, develop, use, sell and distribute Product for the treatment of chronic hepatitis C, in each country in the Territory during the Exclusive Period (1) under the Know-How and (2) at Schering's option, under either the ICN Trademark or the Schering Trademark, and (b) the non-exclusive license in and to the Know-How to enable Schering to make, have made, develop, use, sell and distribute the Product for the treatment of chronic hepatitis C in the Territory during the License Period. The exclusive licenses granted in this Section 2.1 (i) are subject to the rights of ICN retained by or reserved to ICN under this Agreement, including without limitation, the rights to manufacture the Product and to distribute, market and sell the Product as provided for in Section 7.1 hereof; (ii) do not include the right to sublicense, except to Affiliates of Schering; (iii) shall prohibit ICN from selling the Product for the treatment of chronic hepatitis C through any distributorship agreements, marketing arrangements or similar agreements other than those in effect on the Effective Date and set forth in Exhibit 2.1 hereto; and (iv) shall prohibit ICN from selling ribavirin in bulk form to any third parties (except pursuant to agreements relating to respiratory syncytial virus and those agreements set forth on Exhibit 2.1).
Grant of Exclusive License. Subject to Licensee’s continuing full compliance and complete and timely performance of all of the material obligations, terms and conditions imposed on it by this Agreement, Licensor hereby grants to Licensee, with right to grant sublicenses, the sole and exclusive license, during the Term and throughout the Territory, to use, improve, expand and otherwise exploit the Technology, to make (and have made), use, and sell the Licensed Products, and otherwise to practice the inventions and the art that is embodied or described in the Licensor Patents, the Licensor Patent Applications, and any improvements thereto made in whole or in part by Licensor (whether or not patented) in connection with the Technology (the “License”), provided, however, that the terms of any sublicense shall expressly conform and be made subject to the terms and conditions of this Agreement.
Grant of Exclusive License. Owner shall not accept or agree to accept any -------------------------- commission, fee or other compensation from any other party providing services similar to the VelocityHSI Services to the Complexes, nor shall Owner provide or allow for the providing of marketing, promotion, sales, or support of marketing or sales of services similar to the VelocityHSI Services in or on the Complexes.
Grant of Exclusive License. (a) Upon and subject to the terms and conditions set forth in this Agreement, Licensor hereby grants to Licensee, and Licensee hereby accepts, an exclusive license throughout the Territory to use the Trademarks in connection with (i) the operation and distribution of the Channels, (ii) the sub-licensing of Company Programming (other than acquired Supplemental Programs) to third parties, and (iii) non revenue-generating business activities which are ancillary and related to the activities described in (i) and (ii), including but not limited to Trade Materials and the promotion of the Channels and related marketing, distribution and advertising activities; provided, that promotion or marketing over the internet will be limited to the Licensee Web Sites. In addition to the Trademarks, Licensor grants to Licensee, and Licensee hereby accepts, a limited license to use such additional trademarks of Licensor (e.g., "Playmate of the Month") as are included in the programs provided by PEGI under the Program Supply Agreement, which license will be limited solely to customary presentation and logo credits in the title and end credits sequences of such programs and credit blocks in advertising therefor. Notwithstanding the above, Licensee's exclusivity will not apply to: (i) customary presentation and logo credits in the title and end credits sequences of programs licensed to others as permitted in the Program Supply Agreement and credit blocks in advertising therefor; (ii) use of the Trademarks in any television service which is not intended for general reception in the Territory but which is received in the Territory due to unintentional spillover; or (iii) PEGI's right to use the "Playboy" name and logos in connection with the operation of a * * * as defined in and pursuant to the terms of the Operating Agreement. Licensee acknowledges that the Content Categories represent distinct content, style and production values and Licensee will not use, and will not have the right to permit any other Person to use, any Trademark for a use outside its designated Content Category.
Grant of Exclusive License. Intercept hereby grants to DSP an exclusive, royalty-bearing license, including the right to grant sublicenses in accordance with Section 2.1.2, under the Intercept Technology to research, Develop, have Developed, make, have made, use, sell, offer for sale, have sold, import, have imported, export and have exported, register, for the purpose of Commercializing the Product in the Territory, for any and all uses within the Field, subject to the terms and conditions of this Agreement. For clarification, the Parties agree that DSP’s appointing a sublicensee to engage in the Manufacture of the Compound or the Product outside the Territory for the Development and Commercialization of the Product inside the Territory shall not be deemed a breach of this Agreement.
Grant of Exclusive License. Subject to the royalty payment obligations under
Grant of Exclusive License. Upon the terms and subject to the conditions hereinafter set forth, Licensor hereby grants to Licensee, for the term of this Agreement, the exclusive right to use the Protocol in the Territory and for the Permitted Uses, as those terms are hereinafter defined. For the purposes of this Agreement, the “Territory” shall mean the United Sates and the “Permitted Uses” shall mean any use of the Licensor know how and any of its trademarks (the “Licensor Marks”). Consistent with the aforesaid grant, Licensee shall have the right to (i) enter into licensing, joint venture and acquisition agreements with clinics that provide pain management services under the direction of physicians who are properly licensed to practice medicine and qualified to treat patients using the Protocol in the Territory; (ii) establish pharmacies that will be within or associated with clinics acquired by Licensor as permitted by the regulations enforced by the applicable governments within the Territory; and (iii) take such steps that are deemed necessary to develop the business of pain management in the Territory.
Grant of Exclusive License. The Lundqvist hereby grants, and AUT hereby accepts, the sole and exclusive right to market, sell, distribute and otherwise exploit the Product anywhere in the world.
